Autopsy report · NCT00467246

Sub-Cutaneous Insulin in Hyperglycaemic Emergencies

“Ethics approval denied”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

The Royal Bournemouth Hospital

Sponsor type

University, hospital or other

Conditions

Diabetes Mellitus

Interventions

Levemir

Trials that died the same way

• Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
  “No approval from ethical committee” (71% match in meaning)
• Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders
  “Refusal by the Ethics Committee” (71% match in meaning)
• Effects of Root Extract Ashwagandha (KSM-66) on Physiological Stress, Perception of Recovery and Muscle Strength in Youth Footballers
  “Finalising ethics approval before completing.” (70% match in meaning)
• Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19
  “Authorization denied by Ethical Comitee” (65% match in meaning)
• Study of AQUACEL™ Ag Surgical Cover Dressing Following Total Knee Replacement
  “Funding withdrawn before ethical approval granted” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.